SPARCL1 as a biomarker of maladaptive right ventricular remodelling in pulmonary hypertension.
Conclusion: SPARCL1 shows potential as novel biomarker of RV pathological remodelling and is associated with RV maladaptation and ventriculoarterial uncoupling in PH.
PMID: 32248722 [PubMed - as supplied by publisher]
Source: Biomarkers - Category: Research Tags: Biomarkers Source Type: research
More News: Cardiology | Cardiomyopathy | Dilated Cardiomyopathy | Heart | Hypertension | Pulmonary Hypertension | Research | Study